Biotoxtech Co. Ltd
086040StockKQ
2,385.00 ▲ +1.71%
Jun 12, 2026
0
Biotoxtech Co. Ltd
2,385.00 ▲ +1.71%
Jun 12, 2026
086040StockKQ

About the company

Biotoxtech Co., Ltd. engages in the safety evaluation of pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. It is involved in the PK/TK, ADME, and RI analysis, as well as validation and bio analysis; efficacy evaluation and screening materials; clinical pathology and business contract of histopathology; new drug development; and business consulting and vicegerent of nonclinical trial activities. The company's safety evaluation research field includes general toxicity studies, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity studies, immunotoxicity studies, safety pharmacology, ecotoxicology studies, histopathology/clinical pathology, and juvenile animal toxicity studies. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea.

Arberion
Loading market data